Listeria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions:   Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical CancerInterventions:   Biological: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001;   Other: Laboratory Biomarker AnalysisSponsors:   Gynecologic Oncology Group;   Advaxis, Inc.;   National Cancer Institute (NCI)Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2010 Category: Research Source Type: clinical trials